Pfizer’s COVID-19 vaccine designed to target omicron will be ready in March, Albert Bourla, PhD, the drugmaker’s CEO, told CNBC on Jan. 10.
Read the full post on Becker's Hospital Review - Healthcare News
Pfizer’s omicron vaccine will be ready in March, CEO says
